Trademarkia Logo

Canada

C$
CASPIAN THERAPEUTICS
FORMALIZED

on 27 Jun 2024

Last Applicant/ Owned by

Kura Oncology, Inc.

12730 High Bluff Drive, Suite 400San Diego CA 92130

US

Serial Number

2335081 filed on 28th Mar 2024

Correspondent Address

JOHN S. MCKEOWN

(Goldman Sloan Nash & Haber LLP)480 University Avenue, Suite 1700Toronto

ONTARIO

CA

M5G1V2

CASPIAN THERAPEUTICS

Trademark usage description

pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical prep Read More

Classification Information


Class [005]
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions.


Classification kind code

12

Class [042]
Providing medical and scientific research information in the field of treatment of oncological diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of oncological diseases, disorders, and conditions; consulting services in the field of research and development of treatments of oncological diseases, disorders, and conditions; cancer treatment research and development.


Classification kind code

12

Mark Details


Serial Number

2335081

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 22nd Jul 2024
Agent Changed
Submitted for opposition 257
on 27th Jun 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th Jun 2024
Created
Submitted for opposition 31
on 27th Jun 2024
Formalized
Submitted for opposition 228
on 28th Mar 2024
International Registration
Submitted for opposition 30
on 28th Mar 2024
Filed